RUA Life Sciences plc (LON:RUA – Get Free Report)’s stock price hit a new 52-week high during trading on Wednesday . The company traded as high as GBX 28.90 and last traded at GBX 27.90, with a volume of 321564 shares trading hands. The stock had previously closed at GBX 24.50.
RUA Life Sciences Trading Up 13.9%
The company has a quick ratio of 7.32, a current ratio of 4.64 and a debt-to-equity ratio of 18.95. The firm has a market cap of £17.31 million, a price-to-earnings ratio of -2.61 and a beta of 0.95. The business has a 50 day moving average of GBX 21.51 and a 200 day moving average of GBX 18.04.
RUA Life Sciences (LON:RUA – Get Free Report) last issued its quarterly earnings results on Tuesday, June 30th. The company reported GBX (0.33) earnings per share for the quarter. RUA Life Sciences had a negative net margin of 3.26% and a negative return on equity of 2.03%.
RUA Life Sciences Company Profile
The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.
Featured Stories
- Five stocks we like better than RUA Life Sciences
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
- Intel’s Rally Gave It a $20 Billion Opportunity and Now Comes the Hard Part
- Visa’s AI Opportunity Is Hiding in Every Transaction
Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
